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Abstract
Background
Approximately 30–40% of children <1 year of age are Clostridium difficile colonized, and
may represent a reservoir for adult C. difficile infections (CDI). Risk factors for colonization
with toxigenic versus non-toxigenic C. difficile strains and longitudinal acquisition dynamics
in infants remain incompletely characterized.
Methods
Predominantly healthy infants (2 years) were recruited in Oxfordshire, UK, and provided
1 fecal samples. Independent risk factors for toxigenic/non-toxigenic C. difficile coloniza-
tion and acquisition were identified using multivariable regression. Infant C. difficile isolates
were whole-genome sequenced to assay genetic diversity and prevalence of toxin-associ-
ated genes, and compared with sequenced strains from Oxfordshire CDI cases.
Results
338/365 enrolled infants provided 1332 fecal samples, representing 158 C. difficile coloniza-
tion or carriage episodes (107[68%] toxigenic). Initial colonization was associated with age,
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and reduced with breastfeeding but increased with pet dogs. Acquisition was associated
with older age, Caesarean delivery, and diarrhea. Breastfeeding and pre-existing C. difficile
colonization reduced acquisition risk. Overall 13% of CDI C. difficile strains were genetically
related to infant strains. 29(18%) infant C. difficile sequences were consistent with recent
direct/indirect transmission to/from Oxfordshire CDI cases (2 single nucleotide variants
[SNVs]); 79(50%) shared a common origin with an Oxfordshire CDI case within the last ~5
years (0–10 SNVs). The hypervirulent, epidemic ST1/ribotype 027 remained notably absent
in infants in this large study, as did other lineages such as STs 10/44 (ribotype 015); the
most common strain in infants was ST2 (ribotype 020/014)(22%).
Conclusions
In predominantly healthy infants without significant healthcare exposure C. difficile coloniza-
tion and acquisition reflect environmental exposures, with pet dogs identified as a novel risk
factor. Genetic overlap between some infant strains and those isolated from CDI cases sug-
gest common community reservoirs of these C. difficile lineages, contrasting with those line-
ages found only in CDI cases, and therefore more consistent with healthcare-associated
spread.
Introduction
Clostridium difficile remains one of the commonest causes of nosocomial infective diarrhea in
high-income countries[1], increasing costs and morbidity[2]. Community-associated cases
increasingly contribute to disease burden[3]. Children <1 year of age are commonly colonized
with toxigenic and non-toxigenic C. difficile (cross-sectional prevalence 35–40%), decreasing
to adult rates of ~3% by ~8 years[4], with generally similar multi-locus sequence types (STs)/
ribotypes as in adult Clostridium difficile infections (CDI)[5]. A notable exception is the lack
of any observed colonization by epidemic ST1(027) in healthy asymptomatic children[5, 6],
although it is found in hospitalized children[7]. Previously identified risk factors for pediatric
C. difficile colonization or carriage include mode of delivery, age, breastfeeding/nutrition, pre-
vious antibiotic use, and the environment in which the child is residing (e.g. hospitalized, out-
patient)[8–11]; these have, however, been relatively small studies.
Given the high prevalence of C. difficile colonization and carriage in children, we investi-
gated predominantly healthy children2 years old in Oxfordshire, UK, with limited health-
care contact, to determine risk factors for colonization with and acquisition of toxigenic and
non-toxigenic C. difficile. We used WGS, as the most discriminatory typing tool available[12],
to characterize C. difficile strains isolated, their population structure, and their molecular epi-
demiology within individual hosts over time, and compared these with strains isolated from
Oxfordshire CDI cases.
Materials and methods
Study design
All children2 years of age (denoted infants) living in Oxfordshire, UK (population ~653800
people, ~16700 infants[13]), were eligible, provided signed, informed consent was obtained
from their parent/legal guardian. Between March 2010-November 2012 infants were recruited
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from local breastfeeding advice clinics/cafe´s, well-baby clinics (offering routine postnatal
care), nurseries (childcare centers taking children from 4–6 weeks of age) and local vaccine
studies. A minority of infants (16%) was recruited from the John Radcliffe Hospital, Oxford
(emergency department [<48 hours of admission, 14% of participants]; hospital wards [48
hours of admission, 2%]). We chose not to sample newborn nurseries as these were likely to
reflect reservoirs of healthcare-associated strains and our study was focused on predominantly
healthy, community-dwelling infants.
Caregivers provided an initial infant fecal sample and completed a questionnaire covering
putative risk factors for colonization, including those identified in previous infant C. difficile
colonization and carriage studies (Supporting information [a]). Caregivers of infants6
months of age were asked if they would additionally enroll their infant in a longitudinal study,
involving monthly collection of fecal samples and questionnaire data for 9 months (last follow-
up July 2013). Data collected longitudinally included factors recorded at enrolment that could
vary over time (Supporting information [a]).
Given the variability in “normal” infant stooling patterns, we adopted a pragmatic approach
to this definition: Infants were pre-defined as “symptomatic” if they had more frequent/looser
stools according to their caregiver, and “asymptomatic” if their stool pattern was considered
normal by the caregiver. They were considered colonized (or carriers) if one (or more conse-
cutive) isolate(s) cultured from their fecal sample was confirmed as C. difficile by WGS. For the
longitudinal cohort, “acquisition” included a change from either uncolonized to colonized or a
change of C. difficile strain, as defined by WGS. The study was designed to enroll 450 infants
(150 in “symptomatic”,”asymptomatic” groups) to provide80% power to detect differences
of 15% in colonization prevalence between the groups (two-sided α = 0.05). The study was
approved by the Oxford NHS Research Ethics Committee (OxREC C 09/H0606/80).
Genetic comparisons with sequenced Oxfordshire C. difficile infection-
associated isolates
Whole genome sequences from infant C. difficile colonization and carriage were compared
with each other, and with consecutive strains isolated from symptomatic Oxfordshire CDI
cases and potential excretors (denoted Oxfordshire symptomatic patients) identified as part of
routine clinical testing (September 2006-September 2013)[14, 15]. Samples from patients with
diarrhea were submitted from hospital inpatients and primary care for C. difficile testing. To
March 2012, only enzyme-immunoassay (EIA) positive samples were identified; from April
2012 glutamate dehydrogenase (GDH) testing was used as part of a two-step testing process,
and GDH-positive samples were processed for sequencing regardless of whether they were
EIA-negative (presumed C. difficile colonized, with diarrhea of another cause) or EIA-positive
(CDI cases). As part of a C. difficile diagnostic study[16], strains not expressing toxin were also
identified by culture between December 2010 and September 2011 inclusive. 21/2259 [0.9%]
cases where age was known were2 years of age.
Laboratory methods and WGS
DNA was extracted from single colony sub-cultures incubated for 48 hours on Columbia
blood agar[17]. Extracts were sequenced using Illumina HiSeq 2000 technology (Illumina Inc,
San Diego, CA), generating 100 base-pair paired-end reads. Reads were mapped to the C. diffi-
cile reference genome 630 (Genbank: AM180355.1) and sequences compared using single
nucleotide variants (SNVs). SNV differences between samples were obtained from maximum
likelihood phylogenetic trees, initially constructed with PhyML[18], (generalized time revers-
ible substitution model, “BEST” tree topology search operation option), and adjusted to
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remove recombining regions using ClonalFrameML[19] (default parameters)(Supporting
information[b]). Reads were also de novo assembled using Velvet/VelvetOptimiser[20], and
the presence/absence of toxin genes tcdB and/or tcdA (toxigenic C. difficile) and multi-locus
sequence type determined using BLASTn.
Rates of evolution during infant C. difficile carriage
Sequences from the first and last samples for infants carrying the same C. difficile strain were
compared (n = 70), together with sequences from adults with on-going or recurrent CDI
(n = 145)[14], to determine if rates of C. difficile evolution in infants differed from adults. To
estimate evolutionary rates, SNVs were assumed to arise as the combination of a time-depen-
dent Poisson process, representing evolution, and a time-independent Poisson process, repre-
senting within-host diversity/assay variation[21]. This model does not account for time spent
in spore form; however, given that this likely reflects a state with slowed evolutionary rates,
our estimates of genetic similarity were anticipated to be conservative.
Metrics of genetic relatedness. Pairs of sequences varying by2 SNVs were considered
sufficiently closely related to be compatible with recent direct transmission/acquisition from a
common source, given rates of C. difficile evolution and within-host diversity[14]. Pairs of
sequences varying by 0–10 SNVs were considered related through a shared common ancestor
sometime during or shortly before the study (~5 years evolution). Pairs of sequences varying
by>10 SNVs were considered genetically distinct.
Statistical methods
Data collected at baseline (for the colonization analysis) included factors whose effects were
considered important to investigate in multivariable models together with potential confound-
ers: date of birth, gender, birth history (mode of delivery, location of delivery, gestational age,
birth weight), exposure to hospital/long-term healthcare facilities (length of stay in hospital
after birth, date and details of other hospital admissions since birth), relevant medical history
(current diagnoses, past episodes of illness), regular medications including antibiotics, nutri-
tional factors (current breastfeeding, formula milk or solid food intake), presence of pets/ani-
mals at home, whether anyone in the family was working in healthcare, siblings and age of
siblings in the household, non-parental carers, and travel abroad in the last year.
Data collected longitudinally were all those factors collected at enrolment that could vary
over time, namely relevant medical history (new medical problems, visits to GP or hospital),
regular medications including antibiotics, nutritional factors (current breastfeeding, typical
daily meals), presence of pets/animals at home, whether anyone in the family was working in
healthcare, non-parental carers, and travel abroad, all since the last sample was taken.
When named, administered antibiotics were categorized as high risk for C. difficile (co-
amoxiclav, cephalosporins, ciprofloxacin) or not[22, 23]; when not named, they were catego-
rized as unknown risk. All unnamed antibiotics were assumed to be systemic (as 93% of
named antibiotics were systemic). Topical antibiotics were not considered in analysis.
Univariable logistic regression was used to pre-select variables for multivariable analyses
using a significance threshold of p0.2, allowing for non-linearity in continuous variables (i.e.
age, gestation, weight at birth, length of hospital stay after birth, number of medical problems,
number of times admitted to hospital, length of stay for hospital admissions) using fractional
polynomials (Supporting material[c]). Multivariable logistic and Cox regression were used to
identify independent risk factors for initial colonization with C. difficile and acquisition of dis-
tinct strains using backwards elimination (exit p = 0.05) on factors pre-selected above, and
accounting for non-linearity in continuous variables using multivariable fractional
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polynomials. The final models were refitted in “complete cases” for the selected factors or
interactions if p<0.05 (Supporting material[c]). Heterogeneity between risk factors for toxi-
genic and non-toxigenic strains was assessed using multivariable multinomial regression and
stacked regression for colonization and acquisition respectively. Statistical analyses were per-
formed in Stata, version 13.1(StataCorp LP, Texas, USA).
Results
365 infants were enrolled; 26 failed to return either a sample/questionnaire, and one sample
was lost, leaving 338 infants, aged median (IQR) 4.4(1.6–8.7) months, for analysis(Fig 1). Only
seven (2%) had hospital-onset diarrhea (48h after admission); all other participants (98%)
were from the community.
Risk factors for C. difficile colonization at enrolment
Overall 58(17%) infants were colonized with C. difficile at enrolment. 18 factors were associ-
ated with C. difficile colonization with p<0.05 in the univariable analyses(S1 Table); age,
breastfeeding and pet dogs were independently associated(Table 1). Colonization prevalence
increased to ~11 months of age and then decreased(S1 Fig), and was independently lower in
mixed formula/breastfed and breastfed versus non-breastfed infants. Infants in households
with dogs had significantly higher colonization rates; the protective effect of breastfeeding was
attenuated in these households(interaction p = 0.02, S2 Table). Adjusting for these factors (and
the interaction), there was no additional effect on colonization status of an infant having more
frequent/looser versus normal stools (odds ratio [OR] = 1.19, 95%CI [0.56–2.55], p = 0.65),
although power to detect an independent effect was reduced (fewer infants with more fre-
quent/looser stools were recruited than planned, n = 61).
Approximately half the colonized infants (33, 10% overall) had toxigenic C. difficile. There
was no evidence that the effect of age, breastfeeding or pet dogs differed for toxigenic versus
non-toxigenic C. difficile (heterogeneity p>0.2). However, previous use of systemic antibiotics
independently increased the colonization risk by a toxigenic (OR = 2.76, [1.15–6.60]) but not a
non-toxigenic strain (heterogeneity p = 0.02), and having a child-minder (providing non-insti-
tutional childcare, typically with several other children) increased the colonization risk by a
non-toxigenic strain (OR = 6.35, [1.59–25.39])(Table 1).
Risk factors for acquiring a new C. difficile strain
127(38%) infants contributed longitudinal sample(s) with questionnaire data (median [IQR]
follow-up 8 [7–8] months, 1112 samples), and were a median (IQR) 2.5 (1.0–4.1) months old
at enrolment, with lower baseline colonization (11/127, 9%). Enrolment strains were carried
for median (IQR) 4 (2–9) months. 77(61%) infants acquired a new strain post-enrolment, and
25(32%) acquired2 new strains. Older age at enrolment (consistent with S1 Fig), Caesarean
delivery, and diarrhea since the last sample were independently associated with increased risk
of acquiring a new strain (S3 and S4 Tables). Current mixed formula/breastfeeding or exclu-
sive breastfeeding and pre-existing C. difficile colonization independently reduced acquisition
risk.
62(49%) and 28(22%) infants acquired a toxigenic C. difficile and non-toxigenic C. difficile
strain, respectively. There was no evidence that the effect of age, delivery mode, breastfeeding
or previous colonization differed for acquisition of toxigenic versus non-toxigenic C. difficile
(heterogeneity p>0.2; S4 Table); however, there was a weak trend towards diarrhea since the
last sample having a greater effect on acquiring a new toxigenic C. difficile (heterogeneity
p = 0.06). Other effects on acquisition of either toxigenic (cat ownership [p = 0.03,
Clinical and molecular epidemiology of C. difficile in infants in Oxfordshire, UK
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Fig 1. Participant disposition. a The total numbers of individuals screened for recruitment was not recorded.
https://doi.org/10.1371/journal.pone.0182307.g001
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Table 1. Independent risk factors for Clostridium difficile colonization at enrolment.
Overall n
(col %) or
median
(IQR)
C. difficile positive (all
strains), n = 58
Hetero-geneity of
effect in non-
toxigenic versus
toxigenic
Presence of non-toxigenic
strains, n = 25
Presence of toxigenic
strains, n = 33
Risk factor n (row %)
or median
(IQR)
Odds
ratio
(95% CI)
p p n (row %)
or median
(IQR)
Odds
ratio
(95% CI)
p n (row %)
or median
(IQR)
Odds
ratio
(95% CI)
p
Age (months) 4.4 (1.6, 8.7) 8.0 (5.2,
11.8)
Non-
linear*
<0.001 0.48 8.7 (6.1,
10.7)
Non-
linear*
0.001 7.6 (5.2,
12.6)
Non-
linear*
0.03
2 122 (36%)** 8 (7%) 0.36
(0.21,
0.61)
3 (2%) 0.27
(0.12,
0.60)
5 (4%) 0.49
(0.25,
0.97)
4 53 (16%) 3 (6%) 0.59
(0.45,
0.78)
1 (2%) 0.52
(0.34,
0.78)
2 (4%) 0.70
(0.50,
0.99)
6 57 (17%) 6 (11%) 1.00 (ref) 2 (4%) 1.00 (ref) 4 (7%) 1.00 (ref)
9 40 (12%) 16 (40%) 1.77
(1.28,
2.46)
7 (18%) 2.01
(1.23,
3.27)
9 (23%) 1.43
(0.94,
2.19)
12 31 (9%) 12 (39%) 1.98
(1.18,
3.32)
8 (26%) 2.17
(0.97,
4.84)
4 (13%) 1.44
(0.74,
2.81)
15 18 (5%) 8 (44%) 1.17
(0.58,
2.37)
3 (17%) 1.00
(0.28,
3.52)
5 (28%) 0.89
(0.37,
2.13)
18 17 (5%) 5 (29%) 0.32
(0.09,
1.13)
1 (6%) 0.17
(0.02,
1.74)
4 (24%) 0.31
(0.07,
1.35)
Nutrition
No breastfeeding 124 (37%) 41 (33%) 1.00 (ref) 15 (12%) 1.00 (ref) 26 (21%) 1.00 (ref)
Mixed feeding 103 (30%) 14 (14%) 0.40
(0.19,
0.83)
0.01 0.22 8 (8%) 0.70
(0.25,
1.94)
0.49 6 (6%) 0.30
(0.11,
0.82)
0.02
Breastfeeding
only
111 (33%) 3 (3%) 0.13
(0.03,
0.47)
0.002 0.23 2 (2%) 0.31
(0.05,
1.73)
0.18 1 (1%) 0.06
(0.01,
0.50)
0.01
Pet dog*** 58 (17%) 21 (36)% 3.06
(1.47,
6.38)
0.003 0.80 9 (16%) 2.77
(1.02,
7.56)
0.05 12 (21%) 3.23
(1.30,
8.04)
0.01
Ever taken
systemic
antibiotics
83 (25%) 23 (28%) Not selected in
model for
colonization with
any C. difficile
strain
0.02 5 (6%) 0.58
(0.19,
1.82)
0.35 18 (22%) 2.76
(1.15,
6.60)
0.02
Child-minder 14 (4%) 5 (36%) Not selected in
model for
colonization with
any C. difficile
strain
- 5 (36%) 6.35
(1.59,
25.39)
0.01 0 (0%) No cases -
* see S1 Fig.
** n (%) are the numbers of infants aged zero-two months, two-four months etc. Odds ratios for age effect are calculated from the best-fitting fractional
polynomial function using 6 months as the reference category (and are not based on categorized age-groups which are merely shown for reference).
*** Although pet dogs were identified using backwards elimination, similar model fit and effect was found when substituting dogs with cats (main model:
OR = 1.48 p = 0.26 for cats, difference in Akaike Information Criteria: 259(cats)-252(dogs) = 7). See S1 Table for univariable results.
https://doi.org/10.1371/journal.pone.0182307.t001
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heterogeneity p = 0.08], childcare nursery attendance [p = 0.01, heterogeneity p = 0.23]) or
non-toxigenic C. difficile (having a child-minder [p = 0.004, heterogeneity p = 0.02]) reflected
additional environmental exposures (S4 Table).
Genetic analyses and comparisons
The estimated rate of evolution was 0.88 SNVs/year (95% CI 0.35–1.40), with 0.28 SNVs (95%
CI 0.15–0.41) arising from within-host diversity, with no evidence for different evolutionary
rates between C. difficile from adult CDI cases and infants (heterogeneity p = 0.86)(S2 Fig, a
single pair of infant sequences separated by 11 SNVs and 200 days was determined to be more
likely to represent re-colonization with a new strain and excluded, as the second sequence had
been previously found in other participants).
Including enrolment and longitudinal infant samples, 364/1332(27%) contained C. difficile.
Of 355(98%) isolates successfully sequenced, 257(72%) were toxigenic, representing 158 dis-
tinct colonization or carriage episodes in 130 infants. The most common toxigenic STs (equiv-
alent ribotypes) were ST2(020/014/076/220), ST37(017), ST6(005), ST8(002) and ST11(078)
(Fig 2). 3245 C. difficile sequences from 2286 symptomatic Oxfordshire patients were available
for comparison, representing 2425 genetically distinct CDI/colonization episodes (September
2006-September 2013; 21/2259[0.9%] cases with age known were2 years of age). There was
close overlap between STs in infants and local symptomatic patients(Fig 2), with the exception
of ST1(027) and ST10/44(015), both frequent in patients but absent in infants.
Genetic relatedness between infant samples
The first sequence from each infant colonization or carriage episode was compared with all
previous infant sequences. 13/158(8%) were genetically indistinguishable (zero SNVs) from
Fig 2. Clostridium difficile ST prevalence in Oxfordshire infants and symptomatic patients. ST15, ST26 and a subset of ST3 are non-toxigenic
and hence were only identified in symptomatic Oxfordshire patients between December 2010 to September 2011, and from April 2012 to September
2013. Only three infant samples were obtained prior to January 2011, therefore STs from symptomatic patients are shown separately for January
2011 to September 2013 to provide a comparison of the strains circulating during the study. Circle size represents the proportion of strains per ST
within an isolate collection.
https://doi.org/10.1371/journal.pone.0182307.g002
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1 prior sequences in another infant and 25/158(16%) were within two SNVs, i.e. sufficiently
closely related to be compatible with recent direct transmission/acquisition from a common
source, given rates of C. difficile evolution and within-host diversity[14]. There was no evi-
dence of geographic clustering of related isolates within Oxfordshire(Fig 3). 60/158(38%)
infant isolates were within 0–10 SNVs of another infant strain(s)(Fig 4A), i.e. related by a com-
mon ancestor during or shortly before the study (~5 years evolution).
Genetic relatedness of Oxfordshire isolates
Sequences from infant colonization or carriage were compared with prior sequences from
symptomatic Oxfordshire patients from September 2006 onwards, to evaluate whether symp-
tomatic patients were a plausible source of infant C. difficile colonization or carriage. Nine
(6%) of 158 infant colonization or carriage episodes were genetically indistinguishable from a
previous sequence from a symptomatic patient, and 29(18%) and 79(50%) were within two
and ten SNVs, respectively(Fig 4B).
Excluding three infant colonization or carriage episodes pre-January 2011, infant coloniza-
tion or carriage isolates from January 2011 were compared with subsequent strains from
symptomatic patients through September 2013, i.e. exploring if CDI cases could have arisen
from colonized/carrier infants or a shared source. Of 839 symptomatic patients, six(1%) had a
genetically indistinguishable prior infant isolate, and 17(2%) and 122(15%) had a prior infant
strain within two and ten SNVs, respectively(Fig 4C, S3 and S4 Figs). Overall 13% of Oxford-
shire symptomatic patients were within ten SNVs of the Oxfordshire infant strains.
Fig 3. Clusters of infant isolates related within two SNVs. Each isolate is shown as a circle colored according to the infant’s home location on the map.
SNVs between isolates are labeled on the connecting lines. Where indistinguishable sequences were obtained from more than one infant, the size of the
circle is increased and the circle labeled with each isolate’s collection date. *ST 26 and ST15 are non-toxigenic, all other STs shown are toxigenic.
https://doi.org/10.1371/journal.pone.0182307.g003
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Discussion
In this large study of C. difficile isolates from 1,332 fecal samples and 338 infants we demon-
strate close genetic overlap between strains present in colonized, predominantly healthy
infants and those causing CDI. Similar to previous studies, around one-third of infants carried
C. difficile. However, despite the wide diversity of C. difficile in symptomatic patients[14], half
Fig 4. Comparison of the number of SNVs and elapsed time between C. difficile isolates (toxigenic
and non-toxigenic) related within ten SNVs in Oxfordshire. Panel A compares samples from infants to all
prior isolates from infants i.e. whether infants might plausibly be transmitting to other infants; the most closely
related prior sequence is plotted. Panel B compares infants with prior symptomatic patients, i.e. shows
whether symptomatic patients might plausibly be a source of infant carriage or colonization. Panel C
compares infants with subsequent symptomatic patient sequences, i.e. shows where infant carriage is a
potential source of subsequent symptomatic infection. Compatibility with transmission from source to recipient
(either direct or via one or more intermediates) is determined by evolutionary rates (x-axis scales differ); the
95% prediction interval for compatibility with transmission is represented by the shaded blue areas.
https://doi.org/10.1371/journal.pone.0182307.g004
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of the C. difficile carried by infants was sufficiently genetically related to at least one prior
symptomatic patient (predominantly adult CDIs) from Oxfordshire to be compatible with a
common source in the previous five years (within ten SNVs). Furthermore, despite only ~1%
of all Oxfordshire infants being enrolled into the study[24], 2% of symptomatic patients
(again, predominantly adult CDIs) had a sufficiently genetically similar prior infant coloniza-
tion or carriage isolate to support recent direct/indirect transmission, and 15% of symptomatic
patients shared a common source with an infant strain with five years. This overlap could rep-
resent a shared reservoir or direct transmission between infants and CDI cases, although the
temporal-spatial overlap between predominantly healthy children and patients with CDI
might be expected to be reasonably limited. This overlap appears to be predominantly
restricted to a few STs (toxigenic ST2, ST8, and ST11, and non-toxigenic ST15 and ST26).
As in previous, smaller, published surveys of asymptomatic children[5, 6], ST1(NAP1/BI/
027) was notably absent in this population group, suggesting healthcare exposure may be par-
ticularly important for its transmission in this region. This is supported by the relative rarity of
this strain in studies of asymptomatic populations in the community and of community-asso-
ciated CDI cases outside of North America[5, 6, 25–31]. Molecular studies of isolates coloniz-
ing infants in the USA would be warranted, in order to ascertain the epidemiology of infant
colonization and carriage in a setting with high rates of both community-associated and
healthcare-associated CDI attributable to ST1(027)[29].
Independent factors associated with infant C. difficile colonization or acquisition identified
here suggest that many infant-associated lineages may be transmitted from the environment.
Although immunity and the microbiome change with age, increasing age also involves increas-
ing exposure to the wider environment and other children. Exclusive breastfeeding likely
reduces the risk of ingestion of C. difficile as well as potentially exerting immunological effects
on the infant microbiome[32], and exposure to pets and childcare workers/institutions, mode
of birth, antibiotic consumption and pre-existing colonization all reflect the interplay between
predisposition to colonization and varying environmental exposure, given that C. difficile is
present in many environmental substrates, including water, soil and food[33–35]. Pets are rela-
tively commonly colonized with C. difficile, although it is unclear whether this just reflects
wider household C. difficile colonization[36].
This study has several potential limitations. Firstly, we used ethanol shock/selective culture
without enrichment to identify C. difficile, which may have missed low-grade colonization
(<102 CFU/ml)[37]. An alternative, approach might have been a concomitant PCR-based
assay to confirm the proportion of positive samples for which a C. difficile isolate was retriev-
able. Nevertheless, the rates of infant colonization observed in our study are not dissimilar to
those published elsewhere[4]. We may also have missed mixed infections by following up only
single isolates from each case; the prevalence of mixed infection or colonization ranges from
3–13%[38, 39]. Secondly, our study of infant C. difficile was undertaken when ribotype-027/
ST1 was a declining cause of CDI in our region and the UK[14, 40]. Nevertheless, the absence
of ST1(027) in this study was consistent with a previous smaller study in Oxfordshire infants
(November 2008–2009)[5], when ST1(027) caused ~30% CDI cases, but was not found in 128
infants (95% CI:0–2.8%). Thirdly, we did not record the number of infants approached for
participation or reasons for refusal, perhaps resulting in selection bias. However, infants were
recruited from 19/30 Oxfordshire postal districts, including both urban and rural, and affluent
and deprived areas. The fact that only ~1% of infants were sampled suggests that actual pro-
portion of genetically related isolates could be higher; however, sampling was done without
knowledge of lineage and the lineage distributions identified should therefore be robust.
Finally, our study included fewer symptomatic infants than originally planned, and a modest
number of infants overall, meaning power particularly to detect interactions was limited.
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This study confirms factors associated with infant C. difficile colonization identified in
previous studies, and identifies pet dogs as a novel risk factor. In addition, systemic antibiot-
ics represent a specific risk for colonization with toxigenic C. difficile. Strain switching dur-
ing longitudinal carriage is not uncommon in infants. The study also adds to increasing data
that C. difficile transmission may be more heterogeneous than previously appreciated. Over
30% of patients with community-associated CDI do not have typical risk factors, in particu-
lar recent antibiotics or hospitalisation[41]. Our data showing frequent links between some
strains from predominantly healthy, non-hospitalized infants and CDI isolates supports
common community reservoirs of C. difficile; this remains to be investigated in a large and
targeted study.
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